Tumor DNA test may match patients to smarter cancer drugs

NCT ID NCT02342158

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether analyzing the DNA of a patient's tumor can help doctors pick a targeted therapy for advanced or metastatic cancer. Researchers enrolled 550 adults with various solid tumors that had spread. They took biopsy or blood samples to search for genetic changes that could be treated with existing drugs. The goal was to see how often this approach leads to a personalized treatment plan.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could show that routine genetic testing of tumors helps doctors choose more effective, personalized treatments for advanced cancer.

What could go wrong

This is an observational study, not a treatment trial. It only measures how often a genetic target is found, not whether the matched therapy actually works or improves survival.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metastatic neoplasm neoplasm Neoplasm Metastasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Institut Paoli-Calmettes

    Marseille, 13009, France